These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 34921753)

  • 1. Dapagliflozin in patients with COVID-19: mind the kidneys - Authors' reply.
    Kosiborod MN; Esterline R; Oscarsson J; Gasparyan SB; Furtado RHM; Verma S; Berwanger O
    Lancet Diabetes Endocrinol; 2022 Feb; 10(2):98-99. PubMed ID: 34921753
    [No Abstract]   [Full Text] [Related]  

  • 2. Dapagliflozin in patients with COVID-19: mind the kidneys.
    Reis T; Ostermann M; Zarbock A; Kellum JA; Ronco C
    Lancet Diabetes Endocrinol; 2022 Feb; 10(2):97-98. PubMed ID: 34921752
    [No Abstract]   [Full Text] [Related]  

  • 3. Dapagliflozin in patients with COVID-19: truth or dare.
    Rossello X; Caimari F
    Lancet Diabetes Endocrinol; 2021 Sep; 9(9):550-551. PubMed ID: 34302746
    [No Abstract]   [Full Text] [Related]  

  • 4. Can dapagliflozin have a protective effect against COVID-19 infection? A hypothesis.
    Cure E; Cumhur Cure M
    Diabetes Metab Syndr; 2020; 14(4):405-406. PubMed ID: 32335366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of COVID-19 on kidney function - Authors' reply.
    Huang L; Gu X; Wang Y; Huang C; Cao B
    Lancet; 2021 May; 397(10287):1807-1808. PubMed ID: 33992142
    [No Abstract]   [Full Text] [Related]  

  • 6. Association of SARS-CoV-2 renal tropism with acute kidney injury - Authors' reply.
    Braun F; Edler C; Puelles VG; Huber TB
    Lancet; 2020 Dec; 396(10266):1881-1882. PubMed ID: 33308465
    [No Abstract]   [Full Text] [Related]  

  • 7. Unclear conclusions on SARS-CoV-2 elimination versus mitigation - Authors' reply.
    Oliu-Barton M; Pradelski BSR; Aghion P; Artus P; Kickbusch I; Lazarus JV; Vanderslott S
    Lancet; 2021 Oct; 398(10311):1566-1567. PubMed ID: 34755623
    [No Abstract]   [Full Text] [Related]  

  • 8. SARS-CoV-2 and electrocardiography: is electrocardiography a predictor of mortality?-Authors' reply.
    Lanza GA; De Vita A
    Europace; 2021 Jul; 23(7):1151. PubMed ID: 34077534
    [No Abstract]   [Full Text] [Related]  

  • 9. Authors' Reply.
    Farkash EA; Wilson AM; Jentzen JM
    J Am Soc Nephrol; 2020 Sep; 31(9):2225-2226. PubMed ID: 32792369
    [No Abstract]   [Full Text] [Related]  

  • 10. Authors' Reply.
    Rosenstock JL; Bijol V
    J Am Soc Nephrol; 2021 Jan; 32(1):255-256. PubMed ID: 33155987
    [No Abstract]   [Full Text] [Related]  

  • 11. Stability of SARS-CoV-2 in different environmental conditions - Authors' reply.
    Chin AWH; Poon LLM
    Lancet Microbe; 2020 Aug; 1(4):e146. PubMed ID: 33521712
    [No Abstract]   [Full Text] [Related]  

  • 12. The ability of the neonatal immune response to handle SARS-CoV-2 infection - Authors' reply.
    Gale C; Quigley MA; Placzek A; Knight M; Ladhani S; Draper ES; Sharkey D; Doherty C; Mactier H; Kurinczuk JJ
    Lancet Child Adolesc Health; 2021 Mar; 5(3):e8. PubMed ID: 33484657
    [No Abstract]   [Full Text] [Related]  

  • 13. Why the application of IVIG might be beneficial in patients with COVID-19 - Authors' reply.
    Mazeraud A; Wolff M; Lucas B; Sharshar T
    Lancet Respir Med; 2022 Feb; 10(2):e16. PubMed ID: 35120612
    [No Abstract]   [Full Text] [Related]  

  • 14. COVID-19 Vaccine in Children: Where Do We Stand?: Authors' Reply.
    Kasi SG; Shah A
    Indian Pediatr; 2021 Feb; 58(2):195. PubMed ID: 33632967
    [No Abstract]   [Full Text] [Related]  

  • 15. Letter: SARS-CoV-2 infection in two inflammatory bowel disease patients treated with dual targeted therapy-Authors' reply.
    Al-Ani AH; Prentice RE; Rentsch C; Christensen B
    Aliment Pharmacol Ther; 2021 Mar; 53(6):766-767. PubMed ID: 33599326
    [No Abstract]   [Full Text] [Related]  

  • 16. COVID-19 and myocardial infarction - Authors' reply.
    Katsoularis I; Fonseca-Rodríguez O; Farrington P; Lindmark K; Connolly AF
    Lancet; 2021 Nov; 398(10315):1964. PubMed ID: 34838176
    [No Abstract]   [Full Text] [Related]  

  • 17. Antipsychotics and COVID-19: the debate goes on - Authors' reply.
    De Picker L; Mazza MG; Vai B
    Lancet Psychiatry; 2021 Dec; 8(12):1030-1031. PubMed ID: 34801117
    [No Abstract]   [Full Text] [Related]  

  • 18. Authors' Reply to Cattaneo et al.: "Comment on: Comparative Population Pharmacokinetics of Darunavir in SARS-CoV-2 Patients vs. HIV Patients: The Role of Interleukin6".
    Cojutti PG; Londero A; Della Siega P; Givone F; Fabris M; Biasizzo J; Tascini C; Pea F
    Clin Pharmacokinet; 2021 Jun; 60(6):833-834. PubMed ID: 33864624
    [No Abstract]   [Full Text] [Related]  

  • 19. Diuretics and empagliflozin use: authors' reply.
    Álvarez-Rodríguez E; Artola-Menéndez S; González Pérez de Villar N; Díaz Pérez JÁ
    Emergencias; 2018 Ago; 30(4):279-280. PubMed ID: 30033704
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term effects on survivors with COVID-19 - Authors' reply.
    Huang L; Gu X; Cao B
    Lancet; 2021 Nov; 398(10314):1872-1873. PubMed ID: 34801102
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.